| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
1 company
Myszkowski Kenneth Allen is a Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $38.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2018 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $8.00 | $160,000.00 | -6.0% | |
| Aug 23, 2016 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $8.00 | $160,000.00 | -8.0% | |
| Dec 30, 2015 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Financial Officer | Sell | 23,347 | $6.13 | $143,117.11 | -21.5% |